Advert - Leo Pharma – Case AUTH/3527/6/21

Undisclosed transfers of value to patient organisations in 2019


For failures in relation to disclosure of payments made to patient organisations in 2019 and its lack of oversight of overseas affiliate’s interactions with UK based patient organisations, Leo Pharma was ruled in breach of the following clauses of the 2019 Code:

Clause 2 - Bringing discredit upon, and reducing confidence in, the pharmaceutical industry
Clause 9.1 - Failing to maintain high standards
Clause 14.3 - Failing to certify
Clause 27.7 - Failing to disclose an accurate list of patient organisations to which it provided financial support and/or significant indirect/non-financial support